# Emerson Electric Co: Form 10-Q for the period ended Dec 31, 2025

- Company: [Emerson Electric Co](/companies/emr.md) (CIK 32604)
- Form: 10-Q
- Filed: 2026-02-03
- Accepted by EDGAR: Feb 3, 2026, 16:07 ET
- Period: 2025-12-31
- Accession: 0000032604-26-000007
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/32604/000003260426000007/emr-20251231.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/32604/000003260426000007/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2025-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2025-10-01 to 2025-12-31 | $4.35bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months, 2025-10-01 to 2025-12-31 | $2.04bn | us-gaap:CostOfGoodsAndServicesSold |
| Selling, general and administrative | 3 months, 2025-10-01 to 2025-12-31 | $1.24bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Income tax | 3 months, 2025-10-01 to 2025-12-31 | $169.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2025-10-01 to 2025-12-31 | $605.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2025-10-01 to 2025-12-31 | $1.07 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2025-10-01 to 2025-12-31 | $1.08 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2025-10-01 to 2025-12-31 | 564,100,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months, 2025-10-01 to 2025-12-31 | $699.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months, 2025-10-01 to 2025-12-31 | $97.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months, 2025-10-01 to 2025-12-31 | $312.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 3 months, 2025-10-01 to 2025-12-31 | $250.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Current assets | at 2025-12-31 | $8.84bn | us-gaap:AssetsCurrent |
| Total assets | at 2025-12-31 | $41.94bn | us-gaap:Assets |
| Current liabilities | at 2025-12-31 | $10.52bn | us-gaap:LiabilitiesCurrent |
| Long-term debt | at 2025-12-31 | $7.58bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2025-12-31 | $5.83bn | us-gaap:DebtCurrent |
| Shareholders' equity | at 2025-12-31 | $20.28bn | us-gaap:StockholdersEquity |
| Shares outstanding | at 2025-12-31 | 562,000,000 shares | dei:EntityCommonStockSharesOutstanding |

## Management's discussion and analysis

As filed, 781 characters.

| Period | Total Number of Shares Purchased (000s) | Average Price Paid Per Share | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (000s) | Maximum Number of Shares that May Yet Be Purchased Under the Plans or Programs (000s) |
| --- | ---: | ---: | ---: | ---: |
| October 2025 | 1,055 | $132.39 | 1,055 | 18,555 |
| November 2025 | 590 | $130.22 | 590 | 67,965 |
| December 2025 | 248 | $135.17 | 248 | 67,717 |
| Total | 1,893 | $132.08 | 1,893 | 67,717 |

In November 2025, the Board of Directors authorized the purchase of up to 50 million shares. This is in addition to the authorization approved by the Board in March 2020 for the purchase of up to 60 million shares. Approximately 67.7 million shares remain available at December 31, 2025.

## Market risk

As filed, 335 characters.

There has been no significant change in our exposure to market risk during the three months ended December 31, 2025. For a discussion of our exposure to market risk, refer to Item 7A, "Quantitative and Qualitative Disclosures about Market Risk," contained in our Annual Report on Form 10-K for the fiscal year ended September 30, 2025.

## Controls and procedures

As filed, 1,196 characters.

The Company maintains a system of disclosure controls and procedures designed to ensure that information required to be disclosed in its reports under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported in a timely manner. This system also is designed to ensure information is accumulated and communicated to management, including the Company's certifying officers, to allow timely decisions regarding required disclosure. Based on an evaluation performed, the certifying officers have concluded that the disclosure controls and procedures were effective as of the end of the period covered by this report.

Notwithstanding the foregoing, there can be no assurance that the Company's disclosure controls and procedures will detect or uncover all failures of persons within the Company and its consolidated subsidiaries to report material information otherwise required to be set forth in the Company's reports.

There was no change in the Company's internal control over financial reporting during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the Company's internal control over financial reporting.

Filed Feb 3, 2026.
Source: SEC EDGAR, the filing index for accession 0000032604-26-000007. Last ingested by Listed: Nov 4, 2026, 20:00 ET. No prices; not investment advice.